Therapeutic profile of manidipine and lercanidipine in hypertensive patients

Advances in Therapy

Volumn 21, Issue 6, 2004, Pages 357-369

  Casiglia, Edoardo ^a   Mazza, Alberto ^a   Tikhonoff, Valérie ^a   Basso, Giancarlo ^b   Martini, Bortolo ^b   Scarpa, Roberta ^a   Pessina, Achille Cesare ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b General Hospital of Schio   (Italy)

Author keywords

Circulation; Clinical trial; Hypertension; Lercanidipine; Manidipine; Plethysmography; Vasodilator

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; LERCANIDIPINE; MANIDIPINE; PLACEBO;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CAPILLARY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; ESSENTIAL HYPERTENSION; HEADACHE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; TINNITUS; VASCULAR RESISTANCE; VASODILATATION; VERTIGO;

EID: 14944349724     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02850100     Document Type: Article

References (30)

1. Borghi C, Prandin MG, Dormi A, Ambrosini E. Improved tolerability of the dihydropyridine calcium-channel antagonist lercanidipine: the lercanidipine challenge trial. Blood Pressure. 2003; 12(suppl 1):14-21.
2. McClellan KJ, Jarvis B. Lercanidipine: a review of its use in hypertension. Drugs. 2000;60:1123-1140.
3. Arima S, Ito S, Omata K, Tsunoda K, Yaoita H, Abe K. Diverse effects of calcium antagonists on glomerular haemodynamics. Kidney Int. 1996;55(suppl):S132-S134.
4. Sabbatini M, Leonardi A, Testa R, Vitaioli L, Amenta F. Effect of calcium antagonists on glomerular arterioles in spontaneously hypertensive rats. Hypertension. 2000;35:775-779.
5. Campo C, Garcia-Vallejo O, Barrios V, et al. The natriuretic effect of nifedipine gastrointestinal therapeutic system remains despite the presence of mild-to-moderate renal failure. J Hypertens. 1997;15(12 pt 2):1803-1808.
6. Chou TC, Li CY, Yen MH, Ding YA. Antiplatelet effect of amlodipine: a possible mechanism through a nitric oxide-mediated process. Biochem Pharmacol. 1999;58:1657-1663.
7. Buhler FR. Cardiovascular care with the new T-type calcium channel antagonist: possible role of attendant sympathetic nervous system inhibition. J Hypertens Suppl. 1997;15:S3-S7.
8. Simon A, Levenson J. Effects of calcium channel blockers on atherosclerosis: new insights. Acta Cardiol. 2002;57:249-255.
9. Angelico P, Guarnieri N, Leonardi A, Testa R. Vascular-selective effect of lercanidipine and other 1,4-dihydropyridines in isolated rabbit tissues. J Pharm Pharmacol. 1999;51:709-714.
10. Messerli FH. Calcium antagonists in hypertension: from hemodynamics to outcomes. Am J Hypertens. 2002;15(7 pt 2):94S-97S.
11. Fogari R, Malamani GD, Zoppi A, et al. Comparative effect of lercanidipine and nifedipine gastrointestinal therapeutic system on ankle volume and subcutaneous interstitial pressure in hypertensive patients: a double-blind, randomized, parallel-group study. Curr Ther Res Clin Exp. 2000;61:850-862.
12. Lund-Johansen P, Stranden E, Helberg S, et al. Quantification of leg oedema in post-menopausal hypertensive patients treated with lercanidipine or amlodipine. J Hypertens. 2003;21:1003-1010.
13. Leonetti G. Tolerability of long-term treatment with lercanidipine versus amlodipine and lacidipine in elderly hypertensives. Am J Hypertens. 2002;15:932-940.
14. Cheer SM, McClellan K: Manidipine: a review of its use in hypertension. Drugs. 2001;61:1777-1799.
15. Epstein M. Lercanidipine: a novel dihydropyridine calcium-channel blocker. Heart Dis. 2001;3: 398-407.
16. Barrios V, Navarro A, Esteras A, et al. Antihypertensive efficacy and tolerability of lercanidipine in daily clinical practice. The ELYSPE study. Eficacia de Lercanidipino y su Perfil de Seguridad. Blood Press. 2002;11:95-100.
17. Specchia G, Saccaggi SP, Chezzi C. Cardiovascular safety of lercanidipine in patients with angina pectoris: a review of six randomized clinical trials. Curr Ther Res Clin Exp. 2001;62:3-15.
18. Messerli FH. Vasodilatory edema: a common side effect of antihypertensive therapy. Curr Cardiol Rep. 2002;4:479-482.
19. Palatini P, Frigo G, Bertolo O, Roman E, Da Corta R, Winniki M. Validation of the A&D TM-2430 device for ambulatory blood pressure monitoring and evaluation of performance according to subjects' characteristics. Blood Press Monit. 1998;3:255-260.
20. Casiglia E, Petucco S, Pessina AC. Antihypertensive efficacy of amlodipine and enalapril and effects on peripheral blood flow in patients with essential hypertension and intermittent claudication. Clin Drug Invest. 1995;11(suppl):97-101.
21. Sakaguchi S, Ishitobi K, Kameda T. Functional segmental plethysmography with mercury strain gauge. Angiology. 1972;23:127-135.
22. Eichna LW, Wilkins RW. Blood flow to the forearm and calf. Reactive hyperemia: factors influencing the blood flow during vasodilation following ischemia. Bull Johns Hopkins Hosp. 1941;68:450-456.
23. Muiesan ML, Rizzoni D, Zulli R, et al. Cardiovascular characteristics in normotensive subjects with or without family history of hypertension. Clin Exp Hypertens. 1996;18:901-920.
24. Brjiker F, Hejidra YF, Van Den Eishout FJ, Bosch FH, Folgering HT. Volumetric measurements of peripheral oedema in clinical conditions. Clin Physiol. 2000;20:56-61.
25. Karges JR, Mark BE, Stikeleather SJ, Worrell TW. Concurrent validity of upper-extremity volume estimates: comparison of calculated volume derived from girth measurements and water displacement volume. Phys Ther. 2003;83:134-145.
26. Weir MR, Rosenberger C, Fink JC. Pilot study to evaluate a water displacement technique to compare effects of diuretics and ACE inhibitors to alleviate lower extremity edema due to dihydropyridine calcium antagonists. Am J Hypertens. 2001;14:963-968.
27. Parati G, Omboni S, Rizzoni D, Agabiti-Rosei E, Mancia G. The smoothness index: a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension. J Hypertens. 1998;16:1685-1691.
28. Grassi G, Serravalle G, Turri C, Bolla G, Mancia G. Short- versus long-term effects of different dihydropyridines on sympathetic and baroreflex function in hypertension. Hypertension. 2003; 41:558-562.
29. Messerli FH, Grossman E. Pedal edema-not all dihydropyridine calcium antagonists are created equal. Am J Hypertens. 2002;15:1019-1020.
30. Salmasi AM, Belcaro G, Nicolaides AN. Impaired venoarteriolar reflex as a possible cause for nifedipine-induced ankle oedema. Int J Cardiol. 1991;30:303-307.